Biogen · 22 hours ago
Co-op, Portfolio Planning Systems Analyst
Biogen is a mid-sized biotechnology company that focuses on delivering life-changing medicines. They are seeking a Co-op, Portfolio Planning Systems Analyst to work with the Asset Development & Portfolio Management team to improve planning practices through data-based insights and effective performance measures.
BiotechnologyHealth CareNeuroscienceTherapeutics
Responsibilities
Establishing processes for collecting and reporting data to measure portfolio planning and performance effectiveness
Discover data quality issues and assist in identifying root causes, suggesting corrective actions, and deploying solutions
Assist ADPM Operations in identifying and addressing opportunities where ADPM can plan more effectively (continuous improvement)
Qualification
Required
Ability to use data applications – spreadsheets, analysis tools, graphics/visualization tools
Ability to communicate effectively through dialogue, writing, and presentations
Legal authorization to work in the U.S
At least 18 years of age prior to the scheduled start date
Be currently enrolled in an accredited community college, college or university
Bachelors and Masters Degree candidates
Preferred
Project scheduling fundamentals
Database fundamentals
Benefits
Company paid holidays
Commuter benefits
Employee Resource Groups participation
80 hours of sick time per calendar year
Company
Biogen
Biogen is an American biotechnology company that provides therapeutics for neurological, autoimmune, and rare diseases.
H1B Sponsorship
Biogen has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (100)
2024 (93)
2023 (101)
2022 (134)
2021 (104)
2020 (114)
Funding
Current Stage
Public CompanyTotal Funding
$1.5BKey Investors
JP Morgan
2023-08-28Post Ipo Debt· $1.5B
1991-09-27IPO
Leadership Team
Recent News
2026-01-13
2026-01-13
2026-01-13
Company data provided by crunchbase